BACKGROUND AND OBJECTIVES Children use most medications in the ambulatory setting where errors are infrequently intercepted. There is currently no established measure set for ambulatory pediatric medication errors. We have sought to identify the range of existing measures of ambulatory pediatric medication errors, describe the data sources for error measurement, and describe their reliability. METHODS We performed a scoping review of the literature published since 1986 using PubMed, CINAHL, PsycINFO, Web of Science, Embase, and Cochrane and of grey literature. Studies were included if they measured ambulatory, including home, medication errors in children 0 to 26 years. Measures were grouped by phase of the medication use pathway and thematically by measure type. RESULTS We included 138 published studies and 4 studies from the grey literature and identified 21 measures of medication errors along the medication use pathway. Most measures addressed errors in medication prescribing (n = 6), and administration at home (n = 4), often using prescription-level data and observation, respectively. Measures assessing errors at multiple phases of the medication use pathway (n = 3) frequently used error reporting databases and prospective measurement through direct in-home observation. We identified few measures of dispensing and monitoring errors. Only 31 studies used measurement methods that included an assessment of reliability. CONCLUSIONS Although most available, reliable measures are too resource and time-intensive to assess errors at the health system or population level, we were able to identify some measures that may be adopted for continuous measurement and quality improvement.

中文翻译：

---

儿童门诊用药错误的测量：范围界定审查。

背景和目标 儿童在门诊环境中使用大多数药物，很少会出现错误。目前还没有针对门诊儿科用药错误的既定措施。我们试图确定现有儿科门诊用药错误测量的范围，描述错误测量的数据源，并描述其可靠性。方法 我们对 1986 年以来使用 PubMed、CINAHL、PsycINFO、Web of Science、Embase 和 Cochrane 发表的文献以及灰色文献进行了范围界定审查。如果研究测量了 0 至 26 岁儿童的动态（包括家庭）用药错误，则该研究被纳入其中。措施按药物使用途径的阶段进行分组，并按措施类型进行主题分组。结果 我们纳入了 138 项已发表的研究和 4 项来自灰色文献的研究，并确定了药物使用路径中用药错误的 21 项措施。大多数措施针对药物处方（n = 6）和家庭给药（n = 4）中的错误，通常分别使用处方级数据和观察。评估药物使用路径（n = 3）多个阶段错误的措施经常使用错误报告数据库和通过直接家庭观察进行前瞻性测量。我们确定了一些分配和监控错误的措施。只有 31 项研究使用了包括可靠性评估的测量方法。结论 虽然大多数可用、可靠的措施都过于耗费资源和时间，无法评估卫生系统或人口层面的错误，但我们能够确定一些可用于持续测量和质量改进的措施。